Murphy BR

Publishing 1973–1997

Is this you? Claim this profile
14
Articles
7,458
Reads on Journament
50
Co-authors
7
Journals

This page collects the articles indexed under the name Murphy BR. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 14

  1. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant
    Karron RA, Buonagurio DA, Georgiu AF, Whitehead SS, Adamus JE, Clements-Mann ML, Harris DO, Randolph VB, Udem SA, Murphy BR, Sidhu MS
    Proceedings of the National Academy of Sciences of the United States of America 1997 652 reads
  2. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children
    Karron RA, Wright PF, Crowe JE, Clements-Mann ML, Thompson J, Makhene M, Casey R, Murphy BR
    The Journal of infectious diseases 1997 657 reads
  3. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse
    Bukreyev A, Whitehead SS, Murphy BR, Collins PL
    Journal of Virology 1997 656 reads
  4. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines
    Murphy BR, Hall SL, Kulkarni AB, Crowe JE, Collins PL, Connors M, Karron RA, Chanock RM
    virus research 1994 514 reads
  5. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice
    Crowe JE, Murphy BR, Chanock RM, Williamson RA, Barbas CF, Burton DR
    Proceedings of the National Academy of Sciences of the United States of America 1994 556 reads
  6. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies
    Connors M, Kulkarni AB, Collins PL, Firestone CY, Holmes KL, Morse HC, Murphy BR
    Journal of Virology 1992 466 reads
  7. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived
    Connors M, Collins PL, Firestone CY, Murphy BR
    Journal of Virology 1991 496 reads
  8. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization
    Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA
    Vaccine 1990 611 reads
  9. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses
    Murphy BR, Olmsted RA, Collins PL, Chanock RM, Prince GA
    Journal of Virology 1988 580 reads
  10. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus
    Prince GA, Jenson AB, Hemming VG, Murphy BR, Walsh EE, Horswood RL, Chanock RM
    Journal of Virology 1986 444 reads
  11. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection
    Murphy BR, Alling DW, Snyder MH, Walsh EE, Prince GA, Chanock RM, Hemming VG, Rodriguez WJ, Kim HW, Graham BS
    Journal of clinical microbiology 1986 403 reads
  12. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
    Murphy BR, Prince GA, Walsh EE, Kim HW, Parrott RH, Hemming VG, Rodriguez WJ, Chanock RM
    Journal of clinical microbiology 1986 478 reads
  13. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model
    Hemming VG, Prince GA, Horswood RL, London WJ, Murphy BR, Walsh EE, Fischer GW, Weisman LE, Baron PA, Chanock RM
    The Journal of infectious diseases 1985 451 reads
  14. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex
    Parrott RH, Kim HW, Arrobio JO, Hodes DS, Murphy BR, Brandt CD, Camargo E, Chanock RM
    american journal of epidemiology 1973 494 reads

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in